BCL2 and acute lymphoblastic leukemia: The lack of response of T‐ALL cases to venetoclax also concurs with the findings by of Changaile et al., who reported that only the early T‐cell precursor (ETP) subtype was sensitive to venetoclax, indicating this phenotype may be BCL‐2‐dependent.43